About Origin Medical Systems
Origin Medical Systems is a private company based in Cambridge, Massachusetts, incorporated in 2023 in Delaware. It has reported $7,247,517 raised in three offerings on Form D since May 2023. Its chief executive is Jens Thang.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 30, 2025 | Sep 4, 2025 | $550,000of $750K target | 1 | $550K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| May 5, 2023 | May 15, 2023amended Dec 12, 2024 | $6,660,450of $9.1M target | 6 | $1.1M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Apr 14, 2023 | May 15, 2023 | $37,067fully sold | 3 | $12,356 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, three offerings | $7,247,517 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Origin Medical Systems's Form D filed Sep 4, 2025.
Earlier filings also listed Sripad Krishna Devalla (executive officer and promoter, last listed Dec 2024) and Jian Fu Jens Thang (chief executive officer and director, last listed Dec 2024).